Taoliang Chen
Overview
Explore the profile of Taoliang Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma C, Chen J, Ji J, Zheng Y, Liu Y, Wang J, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Aug;
1870(8):167449.
PMID: 39111632
Glioblastoma multiforme (GBM) remains the most lethal central nervous system cancer with poor survival and few targeted therapies. The GBM tumor microenvironment is complex and closely associated with outcomes. Here,...
2.
Chen H, Ji J, Zhang L, Luo C, Chen T, Zhang Y, et al.
Small
. 2024 Feb;
20(29):e2306714.
PMID: 38396320
The blood-brain barrier (BBB) contains tightly connected brain microvascular endothelial cells (BMECs) that hinder drug delivery to the brain, which makes brain tumors difficult to treat. Previous studies have shown...
3.
Hou C, Shi S, Gao M, Ji J, Ma C, Wang T, et al.
J Neurooncol
. 2023 Oct;
165(1):79-90.
PMID: 37819535
Background: The efficacy of current immunotherapeutic strategies for patients with glioblastoma multiforme (GBM) remains unsatisfactory. The purpose of this study was to investigate the correlation between tumor necrosis factor alpha-induced...
4.
Chen H, Ji J, Zhang L, Chen T, Zhang Y, Zhang F, et al.
J Control Release
. 2023 Aug;
362:479-488.
PMID: 37579976
Surgical resection of glioblastoma (GBM) causes brain inflammation that activates and recruits neutrophils (NEs) to residual GBM tissues. NE-based drug delivery using inflammatory chemotaxis is promising for the post-surgical treatment...
5.
Zhong J, Liu J, Huang Z, Zheng Y, Chen J, Ji J, et al.
Front Genet
. 2022 Nov;
13:1026192.
PMID: 36353102
Glioma has the highest fatality rate among intracranial tumours. Besides, the heterogeneity of gliomas leads to different therapeutic effects even with the same treatment. Developing a new signature for glioma...
6.
Zhang Y, Liu J, Mo Y, Chen Z, Chen T, Li Y, et al.
Stem Cells Int
. 2022 Apr;
2022:6430565.
PMID: 35463812
Mesenchymal stem cells (MSCs) have emerged as putative therapeutic tools due to their intrinsic tumor tropism, and anti-tumor and immunoregulatory properties. The limited passage and self-differentiation abilities of MSCs in...
7.
Chen T, Zhang F, Liu J, Huang Z, Zheng Y, Deng S, et al.
Oncogene
. 2021 Jun;
40(32):5081-5094.
PMID: 34188250
Glioma is a devastating cancer with a rich vascular network. No anti-angiogenic treatment is available for prolonging the overall survival of glioma patients. Recent studies have demonstrated that the endothelial...
8.
Xu X, Liu Y, Li Y, Chen H, Zhang Y, Liu J, et al.
J Exp Clin Cancer Res
. 2021 Jan;
40(1):16.
PMID: 33407703
Background: Exosomes are membrane-bound extracellular vesicles of 40-150 nm in size, that are produced by many cell types, and play an important role in the maintenance of cellular homeostasis. Exosome...
9.
Liu J, Zhang Y, Chen T, Chen H, He H, Jin T, et al.
ACS Appl Mater Interfaces
. 2020 Nov;
12(47):52354-52369.
PMID: 33196179
Gliomas-devastating intracranial tumors with a dismal outcome-are in dire need of innovative treatment. Although nanodrugs have been utilized as a target therapy for certain types of solid tumors, their therapeutic...
10.
Liu L, Chen G, Chen T, Shi W, Hu H, Song K, et al.
Stem Cell Res Ther
. 2020 Nov;
11(1):479.
PMID: 33176855
Background: Intrauterine adhesions (IUAs) are manifestations of endometrial fibrosis characterized by inflammation and fibrinogen aggregation in the extracellular matrix (ECM). The available therapeutic interventions for IUA are insufficiently effective in...